Received Apr 9, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (NO BRAND NAME) | UNKNOWN MANUFACTURER | UNK | UNK | — |
The professional eye surgery colleague got Guillian Barre Syndrome from the Shingles Vaccine and can no longer perform delicate eye surgeries; This serious case was reported by a consumer via interactive digital media and described the occurrence of guillain barre syndrome in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis. On an unknown date, the patient received Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced guillain barre syndrome (Verbatim: The professional eye surgery colleague got Guillian Barre Syndrome from the Shingles Vaccine and can no longer perform delicate eye surgeries) (serious criteria GSK medically significant). The outcome of the guillain barre syndrome was not reported. The reporter considered the guillain barre syndrome to be related to Shingles vaccine. The company considered the guillain barre syndrome to be related to Shingles vaccine. Additional Information: GSK Receipt Date: 03-APR-2026 This case was reported by a patient via interactive digital media. The batch number was not provided, and we are unable to contact the reporter.; Sender's Comments: A case of Guillain-Barre syndrome (BCWG insufficient evidence to meet the case definition), on an unknown time after vaccination with unknown dose of Shingles vaccine, in a patient. Based on the available information a possible causality that the event was caused by GSK vaccine product cannot be ascertained. Consent for further follow up has not been received.